Kobe at Eli Lilly and Company

Kobe, Hyogo, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

At least 3 years of experience within the pharmaceutical or related healthcare industry with knowledge of local laws, regulations, guidance, and Codes
Professional-level proficiency in Japanese (speak, read, and write) to operate effectively with industry associations and regulators in Japan
English proficiency to work effectively with ELJEC (Japan leadership)

Responsibilities

Ensure business discussions and decisions consistently consider appropriate ethics and compliance elements
Influence leadership through effective communication of the “state of control,” external environment/risk areas, and internal policies/standards
Work with OBU and Lilly Japan leadership to integrate key elements of an effective compliance program into local governance, business processes, and training
Lead E&C consultation on emerging risk areas. Enable business through partnership and proactive risk mitigation
Collaborate with and influence Alliance Partners to ensure high performance with high integrity in alliance settings
Lead the compliance review and compliance agreement development for new business development deals
Provide input into the development of Corporate Compliance Policies and Procedures that reflect the needs of the affiliate/business you support
Establish win-win relationships with global and IBU E&C colleagues to facilitate shared learning and contribute to global/regional initiatives
Coach and develop people in E&C, including direct reports

Skills

Ethics & Compliance

Risk Assessment

Policy Implementation

Compliance Training

Monitoring

Business Leadership

Oncology

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free